RFS: Development and Validation of a Prediction Model for Refeeding Syndrome in ICU Patients Undergoing Enteral Nutrition Patients
Study Details
Study Description
Brief Summary
This study intends to strengthen the discussion on the risk factors of RFS in critically ill patients, and construct an RFS risk prediction model which is easy for clinical medical staff to use and has a high sensitivity and specificity; In order to help medical staff to identify the high-risk groups of RFS in critically ill patients efficiently and accurately, and take targeted care and treatment for patients, so as to reduce the adverse consequences of RFS on critically ill patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
RFS
|
|
non-RFS
|
Outcome Measures
Primary Outcome Measures
- Occurrence of RFS [from December 1, 2019 to October 31, 2020]
Occurrence of RFS:Within 72 hours after feeding serum phosphorus < 0.0.87mmol/L, or from the baseline levels drop > 0.16% or drop > 30%;And (or) hypokalemia, hypomagnesemia, hypocalcemia and corresponding clinical symptoms.
Eligibility Criteria
Criteria
Inclusion Criteria:
- (1) Age ≥18 years old; (2) Patients with mechanical ventilation; (3) First admission to ICU; (4) The time of receiving enteral nutrition support in ICU was ≥ 3 days.
Exclusion Criteria:
- (1)Ppregnant women or lactating patients;(2) Patients with incomplete information;(3) There are other risk factors leading to hypophosphatemia, such as continuous hemodialysis , hyperphosphatemia treatment,Parathyroid gland resection was performed within 3 months.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Development and Validation of a Prediction Model for Refeeding Syndrome in ICU Patients Undergoing Enteral Nutrition | Hanzhou | Zhejiang | China | 310000 |
Sponsors and Collaborators
- Second Affiliated Hospital, School of Medicine, Zhejiang University
Investigators
- Study Chair: Meiqi Yao, undergraduate, Second Affiliated Hospital, School of Medicine, Zhejiang University
- Principal Investigator: Xingxia Long, postgraduate, HuZhou University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2020-394